Four guidelines on cardiovascular complications and cardiovascular disease, prognosis and treatment in COVID‑19

por Siebelink, H. J., Jansen, C. W., Belfroid, E., Hoogervorst-Schilp, J.
Publicado 2021

Preparedness and the importance of meeting the needs of healthcare workers: a qualitative study on Ebola

por Belfroid, E., van Steenbergen, J., Timen, A., Ellerbroek, P., Huis, A., Hulscher, M.
Publicado 2018

Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients

por Jewbali, L. S. D., Hoogervorst-Schilp, J., Belfroid, E., Jansen, C. W., Asselbergs, F. W., Siebelink, H. J.
Publicado 2021

Identifying the sectors involved in the European public health emergency preparedness and response: a systematic review

por Kengne Kamga, L S, Voordouw, A C G, de Vries, M C, Belfroid, E, Koopmans, M, Timen, A
Publicado 2022

The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients

por van Kimmenade, R. R. J., Belfroid, E., Hoogervorst-Schilp, J., Siebelink, H. J., Janssen, C. W., Pinto, Y.
Publicado 2021

Effect of anticoagulant therapy in COVID-19 patients

por Tieleman, R. G., Klok, F. A., Belfroid, E., Hoogervorst-Schilp, J., Schalkers, I., Jansen, C. W., Siebelink, H. J.
Publicado 2021

How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?

por Habets, M. A. W., Sturkenboom, H. N., Tio, R. A., Belfroid, E., Hoogervorst-Schilp, J., Siebelink, H. J., Jansen, C. W., Smits, P. C.
Publicado 2021